Navigation Links
Neurochem reports results for fourth quarter and fiscal year 2007 and important advances on corporate objectives
Date:2/20/2008

The MAA is being reviewed under the EMEA's centralized procedure. An authorization from the EMEA would apply to all 27 European Union member states, as well as Norway and Iceland.

The decrease in revenue from collaboration agreement for the current periods compared to the same periods in the previous year is mainly attributable to a change in the estimated period over which the non-refundable upfront payment received from Centocor in respect of eprodisate (KIACTA(TM)) is being amortized.

Reimbursable costs revenue amounted to $64,000 for the current quarter ($396,000 for the year), compared to $178,000 for the same period in the previous year ($712,000 for the year) and consists of costs reimbursable by Centocor in respect of eprodisate (KIACTA(TM))-related activities. The Company earns no margin on these reimbursable costs.

Research and development expenses, before research tax credits and grants, amounted to $12,199,000 for the current quarter ($55,732,000 for the year), compared to $14,142,000 for the same period in the previous year ($51,688,000 for the year). The decrease in the current quarter compared to the same period the previous year is mainly attributable to a reduction in expenses incurred in relation to the development of tramiprosate (ALZHEMED(TM)), primarily in respect of the North American Phase III clinical trial. Also, during the second quarter of 2007, the workforce was reduced due to delay encountered in the product candidate development programs. The increase in the current year compared to the same period the previous year is due to expenses incurred in relation to the development of tramiprosate (ALZHEMED(TM)), primarily in respect of the Phase III clinical trial in Europe and the North American open-label extension of the Phase III study, as well as the conduct of a QT cardiac status Phase I study. For the year ended December 31, 2007, research and development expenses also included costs incurred to support the North A
'/>"/>

SOURCE NEUROCHEM INC.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21

Related medicine news :

1. Neurochem to present at 2008 BIO CEO & Investor Conference - Presentation will be Web cast live
2. Neurochem appoints Mr. Gary Schmid as CEO of new nutraceutical business
3. Neurochem to present at JPMorgan Healthcare Conference
4. Neurochem announces European opinion for Eprodisate (KIACTA(TM)) for the treatment of AA amyloidosis
5. Neurochem announces eprodisate (KIACTA(TM)) receives acknowledgement of complete response and is granted Class 2 review
6. Neurochem announces departure of Dr. Philippe Calais, President, Global Business
7. Neurochem reports results for third quarter of fiscal 2007
8. Emageon Reports Fourth Quarter and 2007 Financial Results
9. Cyberonics Reports Operating Profit for Third Quarter FY08 and Announces Share Repurchase Program
10. Platinum Underwriters Holdings, Ltd. Reports Record Fourth Quarter and Year Ended December 31, 2007 Financial Results
11. Onyx Pharmaceuticals Reports Fourth Quarter and Twelve-Month 2007 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/5/2015)... , ... August 05, 2015 , ... Social Security benefits ... participating in a new survey by The Senior Citizens League (TSCL). The ... trouble for an estimated 31 million Social Security beneficiaries age 65 and older, says ...
(Date:8/5/2015)... ... August 05, 2015 , ... ... the testosterone multidistrict litigation known as Testosterone Replacement Therapy Products Liability Litigation, MDL ... of Illinois. The Motion to Dismiss was filed by the defendants, who include ...
(Date:8/5/2015)... ... August 05, 2015 , ... Stelari introduces their new ... yoga wear with their new line, The Earth’s Song. Combining fashion and activewear, Stelari’s ... your workout. Inspired by the Australian Outback, this collection is sure to make the ...
(Date:8/5/2015)... , ... August 05, 2015 , ... " Wildflower Seed ... Report, which takes a look small, medium, and large businesses making an impact in ... business review and shared with viewers how their gardening tools are specifically designed for ...
(Date:8/5/2015)... Palm Coast, Florida (PRWEB) , ... August 05, 2015 , ... ... Inc (CEC) is excited to announce that it has hired Su Barnwell as ... medical education program and faculty management. From 1999 to 2015 she worked for Primary ...
Breaking Medicine News(10 mins):Health News:Majority of Older Americans Say Social Security Benefits Not Keeping up with Rising Household Costs, According to a New Survey from the Senior Citizens League 2Health News:Majority of Older Americans Say Social Security Benefits Not Keeping up with Rising Household Costs, According to a New Survey from the Senior Citizens League 3Health News:Testosterone Lawsuit News: Defendants Push Back Against RICO Claim 2Health News:Testosterone Lawsuit News: Defendants Push Back Against RICO Claim 3Health News:Testosterone Lawsuit News: Defendants Push Back Against RICO Claim 4Health News:Stelari: Bohemian Chic Activewear Line 2Health News:Stelari: Bohemian Chic Activewear Line 3Health News:Wildflower Seed & Tool Company Design Gardening Tools Specifically for Women 2Health News:Leading Continuing Medical Education (CME) Provider, Continuing Education Company (CEC), hires expert Su Barnwell as Director of Program Management 2Health News:Leading Continuing Medical Education (CME) Provider, Continuing Education Company (CEC), hires expert Su Barnwell as Director of Program Management 3
... (Jan. 7, 2010) In the Old West, camps ... or strategy. Likewise, two important signaling molecules communicate across ... from the UT Health Science Center San Antonio reported ... for potential future treatment of epilepsy, stroke and other ...
... Reporter , FRIDAY, Jan. 7 (HealthDay News) -- When you think ... new research finds that skin isn,t the only thing that ages. ... and recede, making you look even older. And if crow,s ... socket gradually widen, the brow bone recedes and the jawbone becomes ...
... The interplay between a major tumor-suppressing gene, a truncated ... basis for explaining the less aggressive form of chronic ... in the Jan. 4 edition of the Journal ... could reveal new mechanisms of resistance to chemotherapy among ...
... By Kathleen Doheny HealthDay Reporter , FRIDAY, ... treat their breast cancer patients -- and whether those ... larger role in whether a cancer returns than experts ... 994 women with ductal carcinoma in situ, the most ...
... -- Researchers have found that brain cells need to ... physically close together, in order to ensure successful brain-wide ... between the right and left sides of the brain ... and sound. Previous research has shown that changes in ...
... Ont., January 7, 2011 People suffering from fatty liver ... stroke than individuals without fatty liver, according to a study ... Sciences Centre. The study is the first to find a ... by the accumulation of fat in the liver in non ...
Cached Medicine News:Health News:Age Takes Toll on Facial Bones, Study Finds 2Health News:Age Takes Toll on Facial Bones, Study Finds 3Health News:MicroRNA-TP53 circuit connected to chronic lymphocytic leukemia 2Health News:MicroRNA-TP53 circuit connected to chronic lymphocytic leukemia 3Health News:Breast Cancer Outcome: Your Doctor Matters 2Health News:Healthy Brain Development May Be a Matter of Timing 2
(Date:8/4/2015)... HARRISBURG, Pa. , Aug. 4, 2015 Governor ... an orthopedic device company that develops and markets implants in ... in Hanover Township , Northampton ... manufacturing operation, a move that will create 25 new, full-time ... Pennsylvania and create more than two ...
(Date:8/4/2015)... FRANCISCO, Calif. , Aug. 4, 2015  Rigel ... for the second quarter and six months ended June ... with fostamatinib in ITP are progressing and we continue ... Raul Rodriguez , president and chief executive officer ... of our other clinical programs, including evaluating fostamatinib for ...
(Date:8/4/2015)... -- Xencor, Inc. (NASDAQ: XNCR ), a clinical-stage ... treatment of autoimmune diseases, asthma and allergic diseases, ... second quarter ended June 30, 2015 and provided a ... eight XmAb® antibody candidates are in clinical testing, ... momentum of this pipeline of antibodies is a ...
Breaking Medicine Technology:Wolf Administration Announces Tyber Medical to Establish Operations and Create New Jobs in Northampton County 2Wolf Administration Announces Tyber Medical to Establish Operations and Create New Jobs in Northampton County 3Rigel Announces Second Quarter 2015 Financial Results 2Rigel Announces Second Quarter 2015 Financial Results 3Rigel Announces Second Quarter 2015 Financial Results 4Rigel Announces Second Quarter 2015 Financial Results 5Rigel Announces Second Quarter 2015 Financial Results 6Xencor Reports Second Quarter 2015 Financial and Operating Results 2Xencor Reports Second Quarter 2015 Financial and Operating Results 3Xencor Reports Second Quarter 2015 Financial and Operating Results 4Xencor Reports Second Quarter 2015 Financial and Operating Results 5Xencor Reports Second Quarter 2015 Financial and Operating Results 6Xencor Reports Second Quarter 2015 Financial and Operating Results 7Xencor Reports Second Quarter 2015 Financial and Operating Results 8Xencor Reports Second Quarter 2015 Financial and Operating Results 9
Medtronic Ophthalmics offers a comprehensive selection of corneal trephine,blades and handles. Handcrafted, sharp, uniform blade edges promote a,symetrical and vertical cut of all corneal layers....
Medtronic Ophthalmics offers a comprehensive selection of corneal trephine,blades and handles. Handcrafted, sharp, uniform blade edges promote a,symetrical and vertical cut of all corneal layers....
Medtronic Ophthalmics offers a comprehensive selection of corneal trephine,blades and handles. Handcrafted, sharp, uniform blade edges promote a,symetrical and vertical cut of all corneal layers....
Medtronic Ophthalmics offers a comprehensive selection of corneal trephine,blades and handles. Handcrafted, sharp, uniform blade edges promote a,symetrical and vertical cut of all corneal layers....
Medicine Products: